VistaGen Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 2010
Net Income	-59.25	-48.71	-42.32	-22.04	-25.73	-15.58	-11.62	-51.42	-13.89	-2.97	Upgrade
Depreciation & Amortization	0.53	0.71	0.48	0.1	0.09	0.08	0.05	0.05	0.06	0.05	Upgrade
Share-Based Compensation	3.34	3.48	2.31	3.82	3.44	2.34	0.85	4.04	2.46	1.14	Upgrade
Other Operating Activities	5.67	-1.69	3.08	1.09	6.53	2.86	2.09	38.32	8.6	-0.35	Upgrade
Operating Cash Flow	-49.72	-45.26	-12.07	-15.76	-14.53	-9.06	-7.26	-4.81	-2.77	-2.13	Upgrade
Capital Expenditures	-0.21	-0.2	-0.28	0	-0.17	-0	-0.24	-0.03	0	-0.01	Upgrade
Acquisitions	-0.53	0	0	0	0	0	0	0	0	0	Upgrade
Investing Cash Flow	-0.74	-0.2	-0.28	0	-0.17	-0	-0.24	-0.03	0	-0.01	Upgrade
Share Issuance / Repurchase	-0.01	10.49	114.48	4.31	17.65	16.72	9.9	0.28	3.15	1.08	Upgrade
Debt Issued / Paid	-1.04	-0	-0.38	-0.3	-0.22	-0.21	-0.18	-0.11	-0.31	0.09	Upgrade
Other Financing Activities	-	-	-	-	-	-	0.28	5.03	-	0.33	Upgrade
Financing Cash Flow	-1.04	10.48	114.1	4.01	17.42	16.52	9.99	5.19	2.84	1.5	Upgrade
Net Cash Flow	-51.5	-34.97	101.75	-11.75	2.72	7.46	2.49	0.36	0.07	-0.64	Upgrade
Free Cash Flow	-49.93	-45.46	-12.35	-15.76	-14.7	-9.06	-7.5	-4.83	-2.77	-2.14	Upgrade
Free Cash Flow Margin	-	-4099.28%	-1133.45%	-	-	-	-600.10%	-	-	-	Upgrade
Free Cash Flow Per Share	-7.17	-6.89	-4.30	-9.86	-15.44	-19.57	-29.88	-82.04	-56.37	-54.85	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).